Drug profile · INN
reteplase
ECOKINASE
reteplase (ECOKINASE) is a tissue-type plasminogen activator exogenous protein. Current US regulatory status: approved.
Drug details — reteplase
- US status
- approved
- Class
- Blood and blood forming organs (B01)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
reteplase (ECOKINASE) is a tissue-type plasminogen activator exogenous protein. Current US regulatory status: approved.
Key facts
Mechanism of action
Tissue-type plasminogen activator exogenous protein
Primary target: Tissue-type plasminogen activator
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | withdrawn | — |
Related & competitor drugs
Frequently asked questions
What is reteplase?
reteplase (ECOKINASE) is a tissue-type plasminogen activator exogenous protein. Current US regulatory status: approved.
What is the brand name for reteplase?
ECOKINASE is a marketed brand name for reteplase. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of reteplase?
reteplase has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.